Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 2, 2010
Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovary
E Chuang, N Wiener, P Christos, et al.
Science (New York, N.Y.)
|
December 18, 1998
Molecular basis of T cell inactivation by CTLA-4
K M Lee, E Chuang, M Griffin, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 11, 1999
Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases
E Chuang, K M Lee, M D Robbins, et al.
British Journal of Cancer
|
December 14, 2006
The role of the VEGF-C/VEGFR-3 axis in cancer progression
J-L Su, C-J Yen, P-S Chen, et al.
Journal of Community Health
|
November 24, 2011
Employment after a breast cancer diagnosis: a qualitative study of ethnically diverse urban women
V S Blinder, M M Murphy, L T Vahdat, et al.
Oncogene
|
August 11, 2015
Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasion
S-Y Yen, S-R Chen, J Hsieh, et al.
Immunity
|
October 6, 2000
The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A
E Chuang, T S Fisher, R W Morgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2003
Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140
H L Parnes, C Cirrincione, J Aisner, et al.
Breast Cancer Research and Treatment
|
December 28, 2011
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo
B Ramaswamy, W Fiskus, B Cohen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2013
Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse
S Jain, J Cohen, M M Ward, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 2, 2010
Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovary
E Chuang, N Wiener, P Christos, et al.
Science (New York, N.Y.)
|
December 18, 1998
Molecular basis of T cell inactivation by CTLA-4
K M Lee, E Chuang, M Griffin, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 11, 1999
Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases
E Chuang, K M Lee, M D Robbins, et al.
British Journal of Cancer
|
December 14, 2006
The role of the VEGF-C/VEGFR-3 axis in cancer progression
J-L Su, C-J Yen, P-S Chen, et al.
Journal of Community Health
|
November 24, 2011
Employment after a breast cancer diagnosis: a qualitative study of ethnically diverse urban women
V S Blinder, M M Murphy, L T Vahdat, et al.
Oncogene
|
August 11, 2015
Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasion
S-Y Yen, S-R Chen, J Hsieh, et al.
Immunity
|
October 6, 2000
The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A
E Chuang, T S Fisher, R W Morgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2003
Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140
H L Parnes, C Cirrincione, J Aisner, et al.
Breast Cancer Research and Treatment
|
December 28, 2011
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo
B Ramaswamy, W Fiskus, B Cohen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2013
Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse
S Jain, J Cohen, M M Ward, et al.
Page
of 7